Category : Search result: dystopian novel


Boehringer Ingelheim Licenses Novel Autoimmune Treatment

Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.

Page 1 of 1